EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
osteosarcoma cell |
- |
761332 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
osteosarcoma cell |
ATCC ROS 17/2.8, strong expression of type I alpha subunit |
657488 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
osteosarcoma cell |
predominantly type I prolyl-4-hydroxylase |
657488 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
osteosarcoma cell |
- |
699120 |
1.2.1.84 | alcohol-forming fatty acyl-CoA reductase |
osteosarcoma cell |
- |
763306 |
1.4.3.13 | protein-lysine 6-oxidase |
osteosarcoma cell |
- |
685931 |
1.6.2.4 | NADPH-hemoprotein reductase |
osteosarcoma cell |
- |
724179 |
2.3.1.255 | N-terminal amino-acid Nalpha-acetyltransferase NatA |
osteosarcoma cell |
higher NAA10 transcripts in metastatic osteosarcoma tissues compared to non-metastatic tissues. MMP-2 expression levels are also significantly correlated with Naa10p levels in osteosarcoma tissues |
756332 |
2.3.2.24 | (E3-independent) E2 ubiquitin-conjugating enzyme |
osteosarcoma cell |
- |
759488 |
2.4.1.224 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase |
osteosarcoma cell |
FBJ, highly metastatic mouse osteosarcoma FBJ-LL cells and the poorly metastatic FBJ-S1 cells are produced from a FBJ virus-induced osteosarcoma |
-, 723170 |
2.4.1.225 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase |
osteosarcoma cell |
FBJ, highly metastatic mouse osteosarcoma FBJ-LL cells and the poorly metastatic FBJ-S1 cells are produced from a FBJ virus-induced osteosarcoma |
-, 723170 |
2.4.1.50 | procollagen galactosyltransferase |
osteosarcoma cell |
- |
699120 |
2.4.1.66 | procollagen glucosyltransferase |
osteosarcoma cell |
- |
699120 |
2.4.2.28 | S-methyl-5'-thioadenosine phosphorylase |
osteosarcoma cell |
decreased or no expression |
687178 |
2.7.1.127 | inositol-trisphosphate 3-kinase |
osteosarcoma cell |
- |
760741 |
2.7.1.153 | phosphatidylinositol-4,5-bisphosphate 3-kinase |
osteosarcoma cell |
- |
751184 |
2.7.1.32 | choline kinase |
osteosarcoma cell |
- |
674066, 737751 |
2.7.11.12 | cGMP-dependent protein kinase |
osteosarcoma cell |
- |
676003 |
2.7.11.24 | mitogen-activated protein kinase |
osteosarcoma cell |
- |
762008 |
2.7.11.30 | receptor protein serine/threonine kinase |
osteosarcoma cell |
- |
665640 |
2.8.2.1 | aryl sulfotransferase |
osteosarcoma cell |
cell lines SaOS-2, U2-OS, PR, and HOS-TE85 |
645678 |
2.8.2.4 | estrone sulfotransferase |
osteosarcoma cell |
- |
693892 |
3.1.26.4 | ribonuclease H |
osteosarcoma cell |
thymidine kinase 1-deficient osteosarcoma cell line |
714345 |
3.1.3.1 | alkaline phosphatase |
osteosarcoma cell |
bone isozyme is of the non-specific type |
653965 |
3.1.3.2 | acid phosphatase |
osteosarcoma cell |
- |
653137 |
3.1.3.48 | protein-tyrosine-phosphatase |
osteosarcoma cell |
- |
680798 |
3.2.1.166 | heparanase |
osteosarcoma cell |
- |
754394 |
3.4.17.12 | carboxypeptidase M |
osteosarcoma cell |
- |
697395 |
3.4.21.73 | u-Plasminogen activator |
osteosarcoma cell |
- |
718270 |
3.4.22.1 | cathepsin B |
osteosarcoma cell |
up-regulation of cathepsin B expression and enhanced secretion in mitochondrial DNA-depleted osteosarcoma cells resulting, at least in part, from the activation of the transcription factor NF-kappaB |
696518 |
3.4.22.15 | cathepsin L |
osteosarcoma cell |
- |
712921 |
3.4.22.38 | cathepsin K |
osteosarcoma cell |
- |
718051 |
3.4.22.49 | separase |
osteosarcoma cell |
increased expression of separase |
697382 |
3.4.22.61 | caspase-8 |
osteosarcoma cell |
- |
708496 |
3.4.22.B26 | calpain 6 |
osteosarcoma cell |
- |
717676 |
3.4.22.B71 | SENP2 peptidase |
osteosarcoma cell |
- |
753521 |
3.4.22.B75 | SENP7 peptidase |
osteosarcoma cell |
- |
731599 |
3.4.24.B18 | m-AAA protease |
osteosarcoma cell |
cell line 143B |
712541 |
3.4.24.B4 | matrix metalloproteinase-13 |
osteosarcoma cell |
overexpression of MMP13 |
711666 |
3.5.3.15 | protein-arginine deiminase |
osteosarcoma cell |
strong expression |
666311 |
3.6.4.10 | non-chaperonin molecular chaperone ATPase |
osteosarcoma cell |
knock-down of mortalin/mtHsp70 causes their growth arrest |
667512 |
3.6.5.5 | dynamin GTPase |
osteosarcoma cell |
- |
718468 |
3.6.5.6 | tubulin GTPase |
osteosarcoma cell |
- |
756504 |
4.2.99.18 | DNA-(apurinic or apyrimidinic site) lyase |
osteosarcoma cell |
APE1 protein is elevated in 72% of the tissues and among those with a known clinical outcome. There is a significant correlation between high APE1 expression levels and reduced survival times |
666309 |
4.2.99.18 | DNA-(apurinic or apyrimidinic site) lyase |
osteosarcoma cell |
osteosarcoma 9901 cell |
747450 |
4.6.1.1 | adenylate cyclase |
osteosarcoma cell |
- |
34774 |
5.6.1.7 | chaperonin ATPase |
osteosarcoma cell |
knock-down of Hsp60 causes their growth arrest |
667512 |
5.6.2.3 | DNA 5'-3' helicase |
osteosarcoma cell |
- |
758118 |
6.3.5.4 | asparagine synthase (glutamine-hydrolysing) |
osteosarcoma cell |
- |
675860 |
7.1.1.9 | cytochrome-c oxidase |
osteosarcoma cell |
- |
692992 |